What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review

Background: To discuss a range of strategic options for China to improve the accessibility of direct antiviral agents (DAAs) as the treatment for hepatitis C. Methods: We adopted a narrative review approach for comprehensive comparisons and in-depth analyses of the country context, and barriers of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jing, Cheng, Hanchao, Hassan, Muhammad Radzi Abu, Chan, Huan-Keat, Piedagnel, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429955/
https://www.ncbi.nlm.nih.gov/pubmed/34590064
http://dx.doi.org/10.1016/j.lanwpc.2021.100261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429955/
https://www.ncbi.nlm.nih.gov/pubmed/34590064
http://dx.doi.org/10.1016/j.lanwpc.2021.100261

Ejemplares similares